Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astellas pharma
atlas venture
audentes therapeutics
1
×
avidity biosciences
biotech
bluebird bio
boston
boston blog main
boston top stories
1
×
clinical trials
1
×
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
joshua brumm
kaleido biosciences
life sciences
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
rare disease drugs
romesh subramanian
san diego blog main
san francisco blog main
susanna high
vertex pharmaceuticals
What
ago
biotechs
considering
data
diseases
drug
1
×
dyne
early
expected
experimental
eyes
genetic
having
humans
ipo
1
×
ipos
1
×
long
medicines
muscle
rare
reach
therapeutics
worked
Language
unset
Current search:
ipo
×
ipos
×
drug
×
" clinical trials "
×
" audentes therapeutics "
×
" boston top stories "
×
@xconomy.com
4 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases